As Tuberculosis (TB) remains a serious public health challenge, the research and development of new anti-TB drugs is an essential component of the global strategy to eradicate TB. The key laboratory of anti-DR TB innovative drug research in Chinese Academy of Medical Sciences was founded in 2018, aiming at the discovery, development, and delivery of safer and more potent anti-TB drugs for the treatment of MDR/XDR-TB.
